Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility

Abstract Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed...

Full description

Bibliographic Details
Main Authors: Patel, Kush K., Venkatesan, Cynthia, Abdelhalim, Habiba, Zeeshan, Saman, Arima, Yuichiro, Linna-Kuosmanen, Suvi, Ahmed, Zeeshan
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format: Article
Language:English
Published: BioMed Central 2023
Online Access:https://hdl.handle.net/1721.1/150862
_version_ 1826213112539250688
author Patel, Kush K.
Venkatesan, Cynthia
Abdelhalim, Habiba
Zeeshan, Saman
Arima, Yuichiro
Linna-Kuosmanen, Suvi
Ahmed, Zeeshan
author2 Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
author_facet Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Patel, Kush K.
Venkatesan, Cynthia
Abdelhalim, Habiba
Zeeshan, Saman
Arima, Yuichiro
Linna-Kuosmanen, Suvi
Ahmed, Zeeshan
author_sort Patel, Kush K.
collection MIT
description Abstract Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed to be critical. To improve the deciphering of CVD mechanisms, we need to deeply investigate well-known and identify novel genes that are responsible for CVD development. With the advancements in sequencing technologies, genomic data have been generated at an unprecedented pace to foster translational research. Correct application of bioinformatics using genomic data holds the potential to reveal the genetic underpinnings of various health conditions. It can help in the identification of causal variants for AF, HF, and other CVDs by moving beyond the one-gene one-disease model through the integration of common and rare variant association, the expressed genome, and characterization of comorbidities and phenotypic traits derived from the clinical information. In this study, we examined and discussed variable genomic approaches investigating genes associated with AF, HF, and other CVDs. We collected, reviewed, and compared high-quality scientific literature published between 2009 and 2022 and accessible through PubMed/NCBI. While selecting relevant literature, we mainly focused on identifying genomic approaches involving the integration of genomic data; analysis of common and rare genetic variants; metadata and phenotypic details; and multi-ethnic studies including individuals from ethnic minorities, and European, Asian, and American ancestries. We found 190 genes associated with AF and 26 genes linked to HF. Seven genes had implications in both AF and HF, which are SYNPO2L, TTN, MTSS1, SCN5A, PITX2, KLHL3, and AGAP5. We listed our conclusion, which include detailed information about genes and SNPs associated with AF and HF.
first_indexed 2024-09-23T15:43:32Z
format Article
id mit-1721.1/150862
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T15:43:32Z
publishDate 2023
publisher BioMed Central
record_format dspace
spelling mit-1721.1/1508622024-02-05T19:59:25Z Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility Patel, Kush K. Venkatesan, Cynthia Abdelhalim, Habiba Zeeshan, Saman Arima, Yuichiro Linna-Kuosmanen, Suvi Ahmed, Zeeshan Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Abstract Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed to be critical. To improve the deciphering of CVD mechanisms, we need to deeply investigate well-known and identify novel genes that are responsible for CVD development. With the advancements in sequencing technologies, genomic data have been generated at an unprecedented pace to foster translational research. Correct application of bioinformatics using genomic data holds the potential to reveal the genetic underpinnings of various health conditions. It can help in the identification of causal variants for AF, HF, and other CVDs by moving beyond the one-gene one-disease model through the integration of common and rare variant association, the expressed genome, and characterization of comorbidities and phenotypic traits derived from the clinical information. In this study, we examined and discussed variable genomic approaches investigating genes associated with AF, HF, and other CVDs. We collected, reviewed, and compared high-quality scientific literature published between 2009 and 2022 and accessible through PubMed/NCBI. While selecting relevant literature, we mainly focused on identifying genomic approaches involving the integration of genomic data; analysis of common and rare genetic variants; metadata and phenotypic details; and multi-ethnic studies including individuals from ethnic minorities, and European, Asian, and American ancestries. We found 190 genes associated with AF and 26 genes linked to HF. Seven genes had implications in both AF and HF, which are SYNPO2L, TTN, MTSS1, SCN5A, PITX2, KLHL3, and AGAP5. We listed our conclusion, which include detailed information about genes and SNPs associated with AF and HF. 2023-06-06T19:06:25Z 2023-06-06T19:06:25Z 2023-06-03 2023-06-04T03:11:04Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/150862 Human Genomics. 2023 Jun 03;17(1):47 PUBLISHER_CC en https://doi.org/10.1186/s40246-023-00498-0 Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ The Author(s) application/pdf BioMed Central BioMed Central
spellingShingle Patel, Kush K.
Venkatesan, Cynthia
Abdelhalim, Habiba
Zeeshan, Saman
Arima, Yuichiro
Linna-Kuosmanen, Suvi
Ahmed, Zeeshan
Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title_full Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title_fullStr Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title_full_unstemmed Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title_short Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
title_sort genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
url https://hdl.handle.net/1721.1/150862
work_keys_str_mv AT patelkushk genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT venkatesancynthia genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT abdelhalimhabiba genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT zeeshansaman genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT arimayuichiro genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT linnakuosmanensuvi genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility
AT ahmedzeeshan genomicapproachestoidentifyandinvestigategenesassociatedwithatrialfibrillationandheartfailuresusceptibility